Lansoprazole - Takeda
Alternative Names: A-65006; AG-1749; Agopton; Bamalite; Estomil; Ilsatec; Lampion; Lansap; Lansone; Lansox; Lanzo; Lanzor; Limpidex; Ogast; Ogastro; Opiren; Prevacid; Prevacid 24HR; Prezal; Pro-Ulco; Takepron; Takepron Capsules 15; Takepron OD Tablets 15; TakepronIV; ZotonLatest Information Update: 05 Nov 2023
At a glance
- Originator Takeda
- Class Antiulcers; Benzimidazoles; Gastric antisecretories; Pyridines; Small molecules; Sulfoxides
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Duodenal ulcer; Dyspepsia; Gastric ulcer; Gastro-oesophageal reflux; Heartburn; Helicobacter infections; NSAID-induced ulcer; Peptic ulcer; Zollinger-Ellison syndrome
- No development reported Gastritis
- Discontinued Bleeding ulcer
Most Recent Events
- 21 Feb 2013 Registered for Gastritis (in combination with amoxicillin and clarithromycin or metronidazole as triple therapy for Helicobacter pylori gastritis) in Japan (PO)
- 02 Jan 2013 Abbott separates its pharmaceuticals business to new company called AbbVie
- 31 Aug 2012 Preregistration for Helicobacter pylori Gastritis (in combination with amoxicillin hydrate, and either clarithromycin or metronidazole) in Japan (PO)